Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 2
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacology and pharmacokinetics of tazemetostat.
Orleni M, Beumer JH. Orleni M, et al. Cancer Chemother Pharmacol. 2024 May;93(5):509-517. doi: 10.1007/s00280-024-04658-4. Epub 2024 Mar 23. Cancer Chemother Pharmacol. 2024. PMID: 38520556 Review.
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure.
Roncato R, Peruzzi E, Gerratana L, Posocco B, Nuzzo S, Montico M, Orleni M, Corsetti S, Bartoletti M, Gagno S, Canil G, De Mattia E, Angelini J, Baraldo M, Puglisi F, Cecchin E, Toffoli G. Roncato R, et al. Among authors: orleni m. Biomed Pharmacother. 2023 Aug;164:114906. doi: 10.1016/j.biopha.2023.114906. Epub 2023 Jun 7. Biomed Pharmacother. 2023. PMID: 37295250 Free article.
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.
Peruzzi E, Gerratana L, Montico M, Posocco B, Corsetti S, Bartoletti M, Gagno S, Orleni M, De Mattia E, Baraldo M, Cecchin E, Puglisi F, Toffoli G, Roncato R. Peruzzi E, et al. Among authors: orleni m. Biomed Pharmacother. 2023 Nov;167:115479. doi: 10.1016/j.biopha.2023.115479. Epub 2023 Sep 19. Biomed Pharmacother. 2023. PMID: 37734262 Free article.
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer.
Roncato R, Gerratana L, Palmero L, Gagno S, Poetto AS, Peruzzi E, Zanchetta M, Posocco B, De Mattia E, Canil G, Alberti M, Orleni M, Toffoli G, Puglisi F, Cecchin E. Roncato R, et al. Among authors: orleni m. Front Pharmacol. 2022 Jul 22;13:897951. doi: 10.3389/fphar.2022.897951. eCollection 2022. Front Pharmacol. 2022. PMID: 35942220 Free PMC article.
"A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A, Posocco B, Zanchetta M, Gagno S, Orleni M, Canil G, Alberti M, Puglisi F, Toffoli G. Soledad Poetto A, et al. Among authors: orleni m. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Sep 1;1207:123403. doi: 10.1016/j.jchromb.2022.123403. Epub 2022 Aug 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35940043
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.
Canil G, Orleni M, Posocco B, Gagno S, Bignucolo A, Montico M, Roncato R, Corsetti S, Bartoletti M, Toffoli G. Canil G, et al. Among authors: orleni m. Pharmaceutics. 2023 May 18;15(5):1524. doi: 10.3390/pharmaceutics15051524. Pharmaceutics. 2023. PMID: 37242766 Free PMC article.
15 results